Company Legal Name
Latest Valuation
Founded Year
Headquarter
Redesign Health operates as a venture studio focused on building and scaling healthcare startups to address critical industry challenges. Founded in 2018 and headquartered in New York, the company leverages its platform approach to systematically identify healthcare pain points and develop targeted solutions through new venture creation. The studio provides comprehensive support including capital, operational expertise, and strategic guidance to portfolio companies navigating complex healthcare markets. Redesign Health's model enables rapid iteration and scaling of healthcare innovations by combining entrepreneurial talent with deep industry knowledge and established infrastructure, positioning the company to capitalize on the growing demand for healthcare transformation solutions.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





